An oncogene regulating chromatin favors response to immunotherapy<subtitle>Oncogene CHAF1A and immunotherapy outcomes</subtitle>

Many biological processes related to cell function and fate begin with chromatin alterations, and many factors associated with the efficacy of immune checkpoint inhibitors (ICIs) are actually downstream events of chromatin alterations, such as genome changes, neoantigen production, and immune checkp...

Description complète

Détails bibliographiques

Auteurs principaux:	Leqian Ying, Zhangmin Hu, Yi Lu, Qing Tao, Fen Xiong, Yongqian Shu, Yufei Yang, Xuehan Qiao, Chen Peng, Yuchun Jiang, Miao Han, Min Xu, Xiaoqin Li, Deqiang Wang
Format:	Artigo
Langue:	Inglês
Publié:	Taylor & Francis Group 2024-12-01
Collection:	OncoImmunology
Sujets:	Cancer CHAF1A immune checkpoint immunotherapy oncogene
Accès en ligne:	https://www.tandfonline.com/doi/10.1080/2162402X.2024.2303195
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!